Dexmedetomidine post-treatment exacerbates metabolic disturbances in septic cardiomyopathy via α2A-adrenoceptor.
Xu Y, Zhang X, Tang X, Zhang C, Cahoon JG, Wang Y, Li H, Lv X, Wang Y, Wang Z, Wang H, Yang D.
Xu Y, et al. Among authors: zhang c, zhang x.
Biomed Pharmacother. 2024 Jan;170:115993. doi: 10.1016/j.biopha.2023.115993. Epub 2023 Dec 12.
Biomed Pharmacother. 2024.
PMID: 38091635
Free article.